The EPO published application EP4233943A2 relates to a medicament delivery device with feedback signalling means, invented by Mattias Daniel and assigned to SHL Medical AG. The device falls under IPC classifications A61M 5/20 and A61M 5/315, covering injection or infusion devices that provide feedback to users. The publication designates multiple European states including AT, BE, DE, FR, GB, IT, NL, SE, and others.

This publication is informational and does not impose compliance obligations. Manufacturers of injection or infusion devices should note this published technology as prior art for Freedom-to-Operate analyses. Competitors developing similar delivery systems should review the claims to assess potential overlap with their own product development efforts.